Abstract:Objective To study the influence of human leucocyte antigen(HLA) and major his-tocompatibility complex class Ⅰ chain-related gene A (MICA) specific antibodies on renal allograft function and graft rejective reaction by monitoring their changes from preoperative to postoperative pe-riods. Methods Twenty-seven patients with renal aliografts were tested with the specificity of anti-HLA antibodies (anti-HLA class Ⅰ and anti-HLA class Ⅱ) and anti-MICA antibodies and their posi-tive value changes by flow PRATM beads. The HLA genotype was integrated to distinguish donor specific antibody(DSA) and non-donor specific antibody(NDSA). Their serum creatinine levels and clinical data were analyzed simultaneously. Results Of the 27 patients, 22 cases accepted renal transplantation from dead bodies and 5 eases accepted from live donors. Except 1 failed patient, the other 26 patients had good functional renal allografts. Twenty-four survival patients were followed up on month 1, 3, 6 and 12 after transplantation. Seven out of 27 patients had pre-exist antibody before transplantation. Among them, 2 patients had anti-HLA antibody; 3 patients had anti-MICA antibody; 2 patients had both anti-HLA and anti-MICA antibody. Three patients with no anti-HLA and anti-MICA antibodies before transplantation created antibodies after transplantation from 3 to 6 months. One patient created NDSA after transplantation and appeared chronic rejection. There were 3 patients who had anti-MICA antibodies before transplantation. The expression levels of antibodies had changed from high to low, but the specific anti-MICA antibody had not changed during the follow-up on month 1, 3, 6 and 12 after transplantation. The patient with pre-transplantation low level of anti-HLA class Ⅱ antibody appeared acute rejection with fever and his CMV was positive as well. The patient's SCr levels changed from 171 μmol/L to 236 μmol/L after I to 3 months post-transplantation. Twenty-four patients were divided into positive and negative groups according to the specific antibody. There was significant difference of SCr levels between the 2 groups 1 month and 1 year after transplantation(P= 0.03, 0.05). Conclusions It is important to detect the specificity and positive value of anti-HLA antibodies and anti-MICA antibody regularly during the post transplantation follow-up. This will make an effective therapy for decreasing the occurrenee and development of acute or chronic rejection and hy-pofunction on renal allograft.

Post-transplantation Antibody Monitoring and HLA Antibody Epitope Identification

Efficacy of Ctla4-Ig in Preventing Acute Rejection of Fully Allogeneic Heart Allografts in Sensitized Recipients

Human Leukocyte Antigen Antibodies for Monitoring Transplant Patients

Incidence and Role of Antibody in Graft Injury: How Can It Best Be Monitored?

Impact of Alloantibody Strength in Crossmatch Negative DSA Positive Kidney Transplantation

Humoral theory of transplantation: some hot topics

Anti-human leukocyte antigens and anti-major histocompatibility complex class I-related chain A antibody expression in kidney transplantation during a four-year follow-up.

Dynamic Analysis of the HLA and MICA Specific Antibody Effect on Renal Allograft Fnnetion

Analysis of Hla Class I Specific Antibodies in Patients with Failed Allografts

Human Leukocyte Antigen Antibodies and Chronic Rejection: from Association to Causation

Identification of endothelial cell surface antigens encoded by genes other than HLA. A combined immunoprecipitation and proteomic approach for the identification of antigens recognized by antibodies against endothelial cells in transplant recipients.

HLA topography enforces shared and convergent immunodominant B cell and antibody alloresponses in transplant recipients

The impact of Anti-HLA and Anti-MICA specific antibodies on allograft function of kidney trans-plant

Prediction of the expression of anti-HLA and anti-MICA specific antibodies to the development of acute rejection and renal graft function

Humoral Theory of Transplantation: Mechanism, Prevention, and Treatment

Outcome-Based Risk Assessment of Non-HLA Antibodies in Heart Transplantation: A Systematic Review

Extremely High Association Between Appearance of Hla Antibodies and Failure of Kidney Grafts in A Five-Year Longitudinal Study

HLA, Non-HLA Antibodies, and Eplet Mismatches in Pediatric Liver Transplantation: Observations from a Small, Single-Center Cohort.

Antibodies Against MICA Antigens and Kidney-Transplant Rejection

Impairment of Renal Allograft Function by Post-Transplant Anti-Hla Antibodies

The Role of Major Histocompatibility Complex Class I Chain-Related Gene A Antibodies in Organ Transplantation